Our Mission

Managing a chronic disease is one of the most difficult tasks patients face. At least one-half of patients do not take their medicines properly or as recommended by their healthcare provider. This problem leads to poor health outcomes, higher healthcare costs, and even death. Unfortunately, solutions to this problem among marginalized populations such as persons with limited health literacy, chronic diseases like diabetes, and communities of color, are lacking.

The Shiyanbola Research Group strives to advance healthy communities by understanding barriers to medication use and adherence, assessing challenges with the management of diabetes and related chronic diseases, and design novel tools and interventions that improve health outcomes. We do this in cooperation with patient, community, academic, and clinical stakeholders.

Our Research Entails

  • Using patient and stakeholder perspectives to understand barriers to medication use and chronic disease self-management among various marginalized populations
  • Examining interdisciplinary approaches to address health literacy and equity gaps in medication use, pharmacy practice, and patient care
  • Developing new measurement tools for providers and researchers to advance their science and practice
  • Designing and implementing novel behavioral clinical trials and interventions to improve diabetes and other related chronic disease outcomes
  • Using mixed methods approaches to assess, design, and implement educational, behavioral, community-based, and clinical interventions

 

Core Focus Areas

Active Grants

  • Enhancing diabetes maNagement with phaRmacIsts and Community Health workers  (ENRxICH)- NIH/NIDDK-funded 5-year study 1R01DK136690-01
  • AHRQ 1R01 HS029477-01
  • Healthy Living for You - NIH/CTSA UW Institute of Clinical and Translational Research (Stakeholder and Patient Engaged Research Pilot)

Listing Row

Wednesday, August 21, 2024
Wednesday, August 21, 2024